For example, Huang and Ulker et al. respectively reported that the expression of SCARA5 was specifically decreased in hepatocellular carcinoma and breast cancer due to promoter methylation [6, 8]. The gene discussed is SCARA5; the disease is hepatocellular carcinoma.